Pro Medicus share price jumps on $32m contract news

Pro Medicus shares are pushing higher on Friday…

| More on:
Doctor looks at a graph on a tablet.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Pro Medicus shares are pushing higher today following a major contract win
  • The company has signed a $32 million, eight-year contract with Inova Health System
  • The deal will see the company’s Visage 7 Enterprise Imaging Platform implemented throughout Inova and Fairfax Radiology via the cloud

The Pro Medicus Limited (ASX: PME) share price is on course to end the week on a positive note.

In early trade, the health imaging technology company's shares were up 4.5% to $49.34.

The Pro Medicus share price has since pulled back but remains up by 2% currently.

Why is the Pro Medicus share price charging higher?

The catalyst for the rise in the Pro Medicus share price on Friday has been the announcement of a major new contract win.

According to the release, the company's US business, Visage Imaging, has signed a $32 million, eight-year contract with Inova Health System.

Inova is the leading non-profit healthcare provider in Northern Virginia. It has 20,000+ team members supporting more than two million patient visits each year through an integrated network of hospitals, primary, and specialty care practices, emergency and urgent care centres, outpatient services, and destination institutes.

The release notes that the agreement is based on a transactional licensing model and will see the company's Visage 7 Enterprise Imaging Platform implemented throughout Inova and Fairfax Radiology. This will provide a unified diagnostic imaging platform across both networks.

Pro Medicus advised that planning for the rollout is to commence immediately, with initial go-lives targeted for the second half of the calendar year.

The implementation will be fully deployed in the public cloud, which management notes is a favourable trend that has taken a foothold in the global healthcare IT market.

Management commentary

Pro Medicus CEO, Dr Sam Hupert, commented: "This is our fourth major contract in the IDN space in less than 18 months which further underpins the strong momentum we continue to build not only in this segment of market but also the North American market as a whole."

"Our pipeline remains strong. Deals like this confirm our view that Visage 7, with its proven cloud native technology provides us with a significant strategic advantage that addresses these opportunities across a growing segment of the market both in North America and other regions."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Pro Medicus Ltd. The Motley Fool Australia owns and has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Technology Shares

A toy house sits on a pile of Australian $100 notes.
Technology Shares

This junior fintech's shares have rocketed almost 20% on good news

Making life easy for renters is proving lucrative.

Read more »

US navy ship at sea.
Growth Shares

Another record in sight? Why this ASX defence stock is back in rally mode

EOS shares surge toward fresh highs as defence spending accelerates and a key South Korean contract decision looms.

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Technology Shares

2 ASX 200 shares that could be top buys for growth

The ASX's biggest growth names still have a lot of potential.

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward.
Technology Shares

Xero breaks below $100 for the first time since 2023. What is happening?

Xero shares have fallen below $100 for the first time since November 2023.

Read more »

Soldier in military uniform using laptop for drone controlling.
Technology Shares

This ASX drone tech stock just hit a record high. Here's why investors are piling in

Elsight shares hit a record high as strong momentum, revenue growth, and insider buying attract investor attention.

Read more »

A woman on a green background points a finger at graphic images of molecules, a rocket, light bulbs and scientific symbols as she smiles.
Technology Shares

2 magnificent ASX tech stocks to buy in 2026

Quietly essential, globally relevant, and built for the long term. These are two ASX tech stocks I’m watching closely in…

Read more »

A child dressed in army clothes looks through his binoculars with leaves and branches on his head.
Opinions

Up 735% in a year! The red-hot EOS share price is smashing Droneshield and other defence stocks

Investor interest in defence stocks has boomed.

Read more »

It's raining cash for this man, as he throws money into the air with a big smile on his face.
Technology Shares

Up 700% in 12 months! Why this ASX tech stock just raised $150m

This high-flying stock is raising funds. But why?

Read more »